Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for Acute Spinal Cord Injury
NCT02096913Phase 1Completed
- Start
- Jun 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ibuprofen in spinal cord injury (SCI) (2 arms). Primary endpoint: Number of patients with severe gastroduodenal bleedings at 4 months. Started Jun 2013; status: completed.
02
Drugs
ibuprofen
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02096913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096913.